GlaxoSmithKline logo

Medical information letter

This letter is sent to healthcare professionals in the United States who request information about suicidality in adults taking paroxetine. A similar letter is shared with healthcare professionals in markets outside the US.





Back to top


Research and development
Research & development
Find out more

About R&D at GSK